Reddys Laboratories News Today

Legislative assembly speaker UT Khader and minister for health and family welfare Dinesh Gundu Rao will inaugurate new facilities at Justice KS Hegde Charitable Hospital including advanced testing and treatment facilities like PET/CT scan and gamma knife. The new annex building commemorates the silver jubilee of KS Hegde Medical Academy, providing specialized treatment facilities for various health conditions.

The Honble Governor launches the 4th edition of Sangam, the flagship convention of IIT Madras Alumni Association (IITMAA)To be conducted in a hybrid mode, Sangam 2021 will have a series of sessions and activities under the theme of 'Restoring Balance in STEM' and the crucial role of 'Women in STEM' "India has made unprecedented progress

Dr Reddys Laboratories Q3 FY24 Results Live : Revenue increased by 6.58% YoY & profit increased by 11.01% YoY

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Dr Reddy's acquires MenoLabs' women health brands in US through Chapter 11 bankruptcy proceeding. The acquisition includes a portfolio of seven branded products for perimenopause and menopause treatment, as well as a health tracker app. Dr Reddy's aims to accelerate growth in the women's nutritional and wellness markets.

Justice C. Hari Shankar of the Delhi High Court recently held that the situs of the High Court which would hear an appeal u/s 117A of the Patents Act would be determined by the location of the...

Hearing a case where an application seeking grant of patent, filed before the Bombay Patent Office, was assigned to the Delhi Patent Office, the Delhi High Court on Thursday posed two interesting...

From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becoming a $100 bn opportunity by 2030. While the drug’s innovator Novo Nordisk launched its oral version in India last year, Dr. Reddys Laboratories has now got approval to carry out bioequivalence studies of injectable semaglu...

/PRNewswire/ -- The Biosimilars Market size is forecast to grow by USD 42.22 billion between 2022 and 2027, and the growth momentum will be accelerating at a...

The article discusses the applicability of the dynamic effect test for the determination of the jurisdiction of a High Court to hear a trademark cancellation petition.